1 0 0 http://purl.obolibrary.org/obo/DIDEO_00000073 evidence information from parallel groups drug-drug interaction clinical trial' 'evidence information from parallel groups drug-drug interaction clinical trial'' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (not ('has part' some 'group randomization')) and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some ('clinical study design' and ('has part' some 'parallel group design')))) and (http://purl.obolibrary.org/obo/OBI_0000293 some (('chemical entity' or 'drug product') and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some (('chemical entity' or 'drug product') and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role'))))) 'evidence information from parallel groups drug-drug interaction clinical trial'' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (not ('has part' value 'group randomization')) and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some ('clinical study design' and ('has part' some 'parallel group design')))) and (http://purl.obolibrary.org/obo/OBI_0000293 some (('chemical entity' or 'drug product') and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some (('chemical entity' or 'drug product') and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role')))))